The group’s principal activity is to invest in sectors including, biopharmaceuticals, drug delivery, drug discovery technologies, generic pharmaceuticals, healthcare services, and medical devices and diagnostics. The group operates from the United States.
Executive Information
Name
Title
Email
Lawrence Lewin
Chmn.
N/A
Amy Boudnitskii
Assist. to Pres.
N/A
Daniel Omstead
CEO, Pres.
N/A
Carolyn Haley
Chief Compliance Officer, VP - Fund Administration
